Research Progress of m6A RNA Methylation in Skin Diseases

被引:4
作者
Liu, Chang [1 ]
Wang, Xin [1 ]
Yang, Shengju [1 ]
Cao, Shuanglin [1 ]
机构
[1] Nantong Univ, Med Sch, Affiliated Hosp, Dept Dermatol, Nantong 226001, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1155/2023/3091204
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
N-6-Methyladenosine (m(6)A) is the most common mRNA modification in eukaryotes and is a dynamically reversible posttranscriptional modification. The enzymes involved in m(6)A modification mainly include methyltransferases (writers), demethylases (erasers), and methylated readers (Readers). m(6)A modification is mainly catalyzed by m(6)A methyltransferase and removed by m(6)A demethylase. The modified RNA can be specifically recognized and bound by m(6)A recognition protein. This protein complex then mediates RNA splicing, maturation, nucleation, degradation, and translation. m(6)A also alters gene expression and regulates cellular processes such as self-renewal, differentiation, invasion, and apoptosis. An increasing body of evidence indicates that the m(6)A methylation modification process is closely related to the occurrence of various skin diseases. In this review, we discuss the role of m(6)A methylation in skin development and skin diseases including psoriasis, melanoma, and cutaneous squamous cell carcinoma.
引用
收藏
页数:10
相关论文
共 78 条
[1]   Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase [J].
Akichika, Shinichiro ;
Hirano, Seiichi ;
Shichino, Yuichi ;
Suzuki, Takeo ;
Nishimasu, Hiroshi ;
Ishitani, Ryuichiro ;
Sugita, Ai ;
Hirose, Yutaka ;
Iwasaki, Shintaro ;
Nureki, Osamu ;
Suzuki, Tsutomu .
SCIENCE, 2019, 363 (6423) :141-141
[2]   Neoadjuvant therapy in melanoma: the next step? [J].
Ascierto, Paolo A. ;
Eggermont, Alexander M. M. .
LANCET ONCOLOGY, 2018, 19 (02) :151-153
[3]  
Bagherani Nooshin, 2016, F1000Res, V5, DOI 10.12688/f1000research.8829.1
[4]   Homeostasis, regeneration and tumour formation in the mammalian epidermis [J].
Belokhvostova, Daria ;
Berzanskyte, Ieva ;
Cujba, Ana-Maria ;
Jowett, Geraldine ;
Marshall, Lucy ;
Prueller, Johanna ;
Watt, Fiona M. .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2018, 62 (6-8) :571-582
[5]   Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis [J].
Cui, Yan-Hong ;
Yang, Seungwon ;
Wei, Jiangbo ;
Shea, Christopher R. ;
Zhong, Wen ;
Wang, Fang ;
Shah, Palak ;
Kibriya, Muhammad G. ;
Cui, Xiaolong ;
Ahsan, Habibul ;
He, Chuan ;
He, Yu-Ying .
NATURE COMMUNICATIONS, 2021, 12 (01)
[6]   RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2 [J].
Dahal, Ujwal ;
Le, Kang ;
Gupta, Mamta .
MELANOMA RESEARCH, 2019, 29 (04) :382-389
[7]   Systemic sclerosis [J].
Denton, Christopher P. ;
Khanna, Dinesh .
LANCET, 2017, 390 (10103) :1685-1699
[8]  
Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586
[9]   N6-Methyldeoxyadenosine Marks Active Transcription Start Sites in Chlamydomonas [J].
Fu, Ye ;
Luo, Guan-Zheng ;
Chen, Kai ;
Deng, Xin ;
Yu, Miao ;
Han, Dali ;
Hao, Ziyang ;
Liu, Jianzhao ;
Lu, Xingyu ;
Dore, Louis C. ;
Weng, Xiaocheng ;
Ji, Quanjiang ;
Mets, Laurens ;
He, Chuan .
CELL, 2015, 161 (04) :879-892
[10]   Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells [J].
Han, Dali ;
Liu, Jun ;
Chen, Chuanyuan ;
Dong, Lihui ;
Liu, Yi ;
Chang, Renbao ;
Huang, Xiaona ;
Liu, Yuanyuan ;
Wang, Jianying ;
Dougherty, Urszula ;
Bissonnette, Marc B. ;
Shen, Bin ;
Weichselbaum, Ralph R. ;
Xu, Meng Michelle ;
He, Chuan .
NATURE, 2019, 566 (7743) :270-+